Approval · Notice of Compliance 34144 · 2024

HERZUMA: Notice of Compliance 34144

Issued October 3, 2024

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number: 34144
Date: October 3, 2024
Company: Celltrion Inc.Incheon, Korea, Republic Of
Product type: Biologic
Submission: New Drug Submission (NDS)
Submission class: Admin
Reason: Administrative ¿ merger/buyout
Canadian reference product: HERCEPTIN

Products in this notice

Brand	DIN	Status today
HERZUMA	02506211	Marketed
HERZUMA	02480794	Marketed

Medicinal ingredients

TRASTUZUMAB 150 MG per VIAL
TRASTUZUMAB 440 MG per VIAL